Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer

NCT06837896 · clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
110
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Qilu Pharmaceutical Co., Ltd.